References
- Lipsker D, Veran Y, Grunenberger F, et al The Schnitzler syndrome. Four new cases and review of the literature. Medicine 2001;80:37–44
- Simon A, Asli B, Braun-Falco M, et al Schnitzler’s syndrome: diagnosis, treatment, and follow-up. Allergy 2013;68:562–8
- de Koning HD, Bodar EJ, van der Meer JW, et al Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37:137–48
- Néel A, Henry B, Barbarot S, et al Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler’s syndrome: a French multicenter study. Autoimmun Rev. 2014;13:1035–41
- de Koning HD, Schalkwijk J, van der Ven-Jongekrijg J, et al Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler’s syndrome. Ann Rheum Dis. 2013;72:1634–8
- Krause K, Weller K, Stefaniak R, et al Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study. Allergy 2012;67:943–50
- Martinez-Taboada VM, Fontalba A, Blanco R, Fernández-Luna JL. Successful treatment of refractory Schnitzler syndrome with anakinra: comment on the article by Hawkins et al. Arthritis Rheum. 2005;52:2226–7
- Gran JT, Midtvedt Ø, Haug S, Aukrust P. Treatment of Schnitzler’s syndrome with anakinra: report of three cases and review of the literature. Scand J Rheumatol. 2011;40:74–9
- Lipsker D. The Schnitzler syndrome. Orphanet J Rare Dis. 2010;5:38. doi:10.1186/1750-1172-5-38
- Dinarello CA, Simon A, van der Meer JW. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 2012;11:633–52
- Eiling E, Möller M, Kreiselmaier I, et al Schnitzler syndrome: treatment failure to rituximab but response to anakinra. J Am Acad Dermatol. 2007;57:361–4
- Volz T, Wölbing F, Fischer J, et al Dermal interleukin-1 expression and effective and long-lasting therapy with interleukin-1 receptor antagonist anakinra in Schnitzler syndrome. Acta Derm Venereol. 2012;92:393–4
- Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355–9
- Dinarello CA. Interleukin-1. Cytokine Growth Factor Rev. 1997;8:253–65
- Ryan JG, de Koning HD, Beck LA, et al IL-1 blockade in Schnitzler syndrome: ex vivo findings correlate with clinical remission. J Allergy Clin Immunol. 2008;121:260–2
- de Koning HD. Schnitzler’s syndrome: lessons from 281 cases. Clin Transl Allergy. 2014;4:41
- Gran JT, Midtvedt Ø, Haug S. [A woman with recurrent urticaria, joint pain and fever]. Tidsskr nor Laegeforen. 2011;131:135–6